These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 17550310)

  • 21. Surgical removal of amyloid-laden lymph nodes: a possible therapeutic approach in a primary systemic AL amyloidosis patient with focal lymphadenopathy.
    Matsuda M; Katoh N; Tazawa K; Shimojima Y; Mishima Y; Sano K; Ikeda S
    Amyloid; 2011 Jun; 18(2):79-82. PubMed ID: 21401322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Equine cutaneous amyloidosis derived from an immunoglobulin lambda-light chain. Immunohistochemical, immunochemical and chemical results.
    Linke RP; Geisel O; Mann K
    Biol Chem Hoppe Seyler; 1991 Sep; 372(9):835-43. PubMed ID: 1772596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formation of immunoglobulin light chain amyloid oligomers in primary cutaneous nodular amyloidosis.
    Clos AL; Lasagna-Reeves CA; Castillo-Carranza DL; Sengupta U; Jackson GR; Kelly B; Beachkofsky TM; Kayed R
    Br J Dermatol; 2011 Dec; 165(6):1349-54. PubMed ID: 21729025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polyclonal Localized Light Chain Amyloidosis-A Distinct Entity?
    Ravindran A; Grogg KL; Domaas DA; Go RS
    Clin Lymphoma Myeloma Leuk; 2016 Oct; 16(10):588-592. PubMed ID: 27600986
    [No Abstract]   [Full Text] [Related]  

  • 25. [Amyloidosis AL].
    Ascari E; Bellotti V; Perfetti V; Bucciarelli E; Merlini G
    Haematologica; 1989 Oct; 74(5 Suppl):51-65. PubMed ID: 2512233
    [No Abstract]   [Full Text] [Related]  

  • 26. Amyloidosis: current trends in its investigation.
    Cohen AS; Cathcart ES; Skinner M
    Arthritis Rheum; 1978; 21(1):153-60. PubMed ID: 414758
    [No Abstract]   [Full Text] [Related]  

  • 27. Amyloid deposits and amyloidosis. The beta-fibrilloses (first of two parts).
    Glenner GG
    N Engl J Med; 1980 Jun; 302(23):1283-92. PubMed ID: 6154243
    [No Abstract]   [Full Text] [Related]  

  • 28. Light chain amyloidosis of the urinary bladder. A site restricted deposition of an externally produced immunoglobulin.
    Livneh A; Shtrasburg S; Martin BM; Baniel J; Gal R; Pras M
    J Clin Pathol; 2001 Dec; 54(12):920-3. PubMed ID: 11729210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Typing of amyloidosis in renal biopsies: diagnostic pitfalls.
    Satoskar AA; Burdge K; Cowden DJ; Nadasdy GM; Hebert LA; Nadasdy T
    Arch Pathol Lab Med; 2007 Jun; 131(6):917-22. PubMed ID: 17550319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The classification and typing of amyloid deposits.
    Gertz MA
    Am J Clin Pathol; 2004 Jun; 121(6):787-9. PubMed ID: 15198347
    [No Abstract]   [Full Text] [Related]  

  • 31. Larynx amyloidosis.
    Akst LM; Thompson LD
    Ear Nose Throat J; 2003 Nov; 82(11):844-5. PubMed ID: 14661432
    [No Abstract]   [Full Text] [Related]  

  • 32. Primary localized amyloidosis of the eyelid: two cases of immunoglobulin light chain-derived proteins, subtype lambda V respectively lambda VI.
    Olsen KE; Sandgren O; Sletten K; Westermark P
    Clin Exp Immunol; 1996 Nov; 106(2):362-6. PubMed ID: 8918586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical study of immunoglobulin light chain amyloidosis with antibodies to the immunoglobulin light chain variable region.
    Hoshii Y; Kiyama M; Cui D; Kawano H; Ishihara T
    Pathol Int; 2006 Jun; 56(6):324-30. PubMed ID: 16704496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunopathology of the amyloid diseases.
    Franklin EC
    Hosp Pract; 1980 Sep; 15(9):70-7. PubMed ID: 6773875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of an amyloid fibril protein from localized amyloidosis of the skin as lambda immunoglobulin light chains of variable subgroup I (A lambda I).
    Husby G; Sletten K; Blumenkrantz N; Danielsen L
    Clin Exp Immunol; 1981 Jul; 45(1):90-6. PubMed ID: 6796317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amyloid fibril protein AA in Papua New Guinean amyloidosis.
    Anders RF; Price MA; Wilkey IS; Husby G; Takitaki F; Natvig JB; McAdam KP
    Clin Exp Immunol; 1976 Apr; 24(1):49-53. PubMed ID: 820500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An investigation of the protein components of amyloid using immunoperoxidase and permanganate methods on tissue sections.
    Looi LM
    Pathology; 1986 Jan; 18(1):137-40. PubMed ID: 2425332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Typing of amyloidoses intra vitam by tissue biopsy using antibodies. Report on 2 patients].
    Fischer JL; Cyran J; Linke RP
    Internist (Berl); 1986 Feb; 27(2):113-7. PubMed ID: 3514520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of systemic lambda-light chain amyloidosis in a patient with gamma-heavy chain deposition disease during long-term follow-up.
    Komatsuda A; Maki N; Wakui H; Ohtani H; Hatakeyama T; Yasuda T; Nakamoto Y; Imai H; Sawada K
    Nephrol Dial Transplant; 2005 Feb; 20(2):434-7. PubMed ID: 15673693
    [No Abstract]   [Full Text] [Related]  

  • 40. Immunoglobulin allotypes are not involved in systemic amyloidosis.
    Ockhuizen T; Westra H; Bijzet J; Post J; van Leeuwen M; van Rijswijk M
    J Rheumatol; 1985 Aug; 12(4):742-6. PubMed ID: 3932652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.